Please Wait
Applying Filters...
menu
    • menu
    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Certepetide

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lisata Therapeutics Showcases Certepetide Preclinical Data
    Lisata Therapeutics Showcases Certepetide Preclinical Data

    04 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/04/3180798/18623/en/Lisata-Therapeutics-Highlights-Positive-Preclinical-Data-of-Certepetide-as-Part-of-Antibody-Drug-Conjugate-Combinations-as-Reported-by-Licensing-Partner-Catalent.html

    GLOBENEWSWIRE
    04 Nov 2025
    Share Share
    Lisata & Catalent Announce Global ADC License Agreement
    Lisata & Catalent Announce Global ADC License Agreement

    08 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/08/3163348/18623/en/Lisata-Therapeutics-and-Catalent-Announce-Global-Antibody-Drug-Conjugate-ADC-License-Agreement.html

    GLOBENEWSWIRE
    08 Oct 2025
    Share Share
    Lisata Therapeutics Gains New Patent for Certepetide Composition
    Lisata Therapeutics Gains New Patent for Certepetide Composition

    15 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/15/3115507/18623/en/Lisata-Therapeutics-Expands-Intellectual-Property-Portfolio-with-New-Composition-of-Matter-Patent-for-Certepetide.html

    GLOBENEWSWIRE
    15 Jul 2025
    Share Share
    Lisata Therapeutics Announces Research License with Catalent
    Lisata Therapeutics Announces Research License with Catalent

    15 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/15/3061666/18623/en/Lisata-Therapeutics-Announces-Research-License-with-Catalent.html

    GLOBENEWSWIRE
    15 Apr 2025
    Share Share
    Lisata & Warpnine Show Encouraging Results For Certepetide In PDAC
    Lisata & Warpnine Show Encouraging Results For Certepetide In PDAC

    23 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/23/3014226/18623/en/Lisata-Therapeutics-and-WARPNINE-Announce-Encouraging-Preliminary-Results-from-the-Phase-1b-2a-iLSTA-Trial-Evaluating-Certepetide-in-Locally-Advanced-Non-Resectable-Pancreatic-Duct.html

    GLOBENEWSWIRE
    23 Jan 2025
    Share Share
    Lisata Therapeutics Reports Ph 2 Data On Certepetide For Cancer
    Lisata Therapeutics Reports Ph 2 Data On Certepetide For Cancer

    22 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/22/3013425/18623/en/Lisata-Therapeutics-Reports-Encouraging-Preliminary-Cohort-A-Data-from-the-AGITG-led-Phase-2-ASCEND-Trial-Evaluating-Certepetide-with-Standard-of-Care-Chemotherapy-in-Metastatic-Pa.html

    GLOBENEWSWIRE
    22 Jan 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.